lupus.bmj6d
Altered structural and functional homotopic connectivity associated with cognitive changes in SLE
Objective Previous studies have revealed functional changes within the cerebral hemispheres of patients with SLE; however the ...
lupus.bmj9d
Development of a predictive model for systemic lupus erythematosus incidence risk based on environmental exposure factors
Objective Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by a loss of immune tolerance, affecting ...
lupus.bmj2d
HNF-1β alleviates podocyte injury in lupus nephritis by maintaining endoplasmic reticulum homeostasis
Objective The current study aims to elucidate the critical function of hepatocyte nuclear factor 1-beta (HNF1-β) in lupus nephritis (LN) by investigating its modulation of the ...
lupus.bmj2d
Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort
Objective To evaluate modified versions of the Belimumab International Study in Lupus Nephritis (BLISS-LN) belimumab study primary efficacy renal response (mPERR) and complete renal response (mCRR) ...
lupus.bmj5d
Rapid Response submission form
No HTML tags allowed. Web page addresses and e-mail addresses turn into links automatically. Lines and paragraphs break automatically.
lupus.bmj3d
Myocardial Performance Index to assess cardiac function in autoimmune connective tissue disease: a systematic review and meta-analysis
Objectives This study aimed to evaluate cardiac function using Myocardial Performance Index (MPI) in autoimmune connective tissue disease (ACTD) patients without cardiovascular abnormalities. Methods ...
lupus.bmj5d
Role of intravenous immunoglobulins in the management of systemic lupus erythematosus: a single-centre experience
Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown aetiology that can affect almost any organ in the body. Although there are no specific guidelines for the use ...
lupus.bmj3d
11 Remission and low disease activity: the new targets for treatment
In chronic inflammatory diseases such as rheumatoid arthritis, attainment of a specific cut-off of low (or even absent) disease activity has been associated with favourable long-term disease outcomes.